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In response to an outbreak of Crimean-Congo 
hemorrhagic fever in western Afghanistan, we measured 
immunoglobulin G seroprevalence among household 
members and their animals. Seroprevalence was 11.2% 
and 75.0% in humans (n = 330) and livestock (n = 132), 
respectively. Persons with frequent exposure to cattle had 
an elevated risk of being immunoglobulin G positive.
C
rimean-Congo hemorrhagic fever (CCHF) is a vector-
borne hemorrhagic disease caused by a primarily 
zoonotic virus infecting a wide range of domestic and wild 
animals. The main implicated vectors are Hyalomma spp. 
ticks. Transmission of the virus to humans occurs through 
tick bites; crushing of infected ticks; contact with blood, 
body ﬂ  uids, and tissue of patients with CCHF during the 
acute phase of illness; and contact with blood or tissue 
of viremic livestock (1). In recent years, several CCHF 
outbreaks were reported in Afghanistan, and the disease 
persists in neighboring countries (2,3). In March 1998, an 
outbreak with 19 cases and 12 deaths (case fatality rate 
63.2%) was reported from Takhar Province in the northern 
part of the country (4).
In the fall of 2008, an outbreak occurred in Herat City, 
western Afghanistan, with ≈60 suspected cases. CCHF 
was identiﬁ  ed in 6 specimens at the Central Public Health 
Laboratory in Kabul and later conﬁ  rmed at the laboratories 
of the US Naval Medical Research Unit No. 3 (NAMRU-3) 
in Cairo, Egypt. In August 2009, we conducted a cross-
sectional seroprevalence survey among livestock-owning 
households in the same districts of Herat City where the 
outbreak occurred.
The Study
The study was conducted in 100 households of 9 
affected villages of Engil District on the edge of Herat 
City. Households were included if they were located on 
3 randomly selected transect lines and if members of the 
households owned either cattle or sheep. Because there 
are no reliable estimates on seroprevalence of CCHF in 
Afghanistan, we estimated prevalence of immunoglobulin 
(Ig) G to be 7% (2,3). A sample size of 160 persons was 
required to detect this prevalence at the 95% conﬁ  dence 
level. Allowing for cluster sampling at the household level, 
320 persons was the target sample size (≈90 households, 
assuming an average of 3.5 persons >15 years of age per 
household). From each household, all members >15 years 
were surveyed, if they gave consent. Sheep and cattle 
were selected as livestock types, and 1 or 2 animals per 
household were randomly selected.
Inclusion criteria for humans were residing in a 
livestock-owning household, giving informed consent, 
being >15 years of age, willing to answer the risk factor 
questionnaire, and willing to give 5 mL of blood. For 
collection of blood samples and vector specimens from 
sheep and cattle, permission was given by the head of 
household.
A standardized, structured, and pretested questionnaire 
that covered individual data for each participant, including 
personal details, exposure variables, and self-reported 
disease history, was used. Animal data were collected from 
each household and included each animal’s origin, tick 
exposure, age, and sex. Information was reported by the 
head of household or owner of the animal(s).
Blood samples from human participants were 
collected by trained health workers according to standard 
procedures. A veterinarian collected blood and tick 
samples from livestock subjects. Blood samples were 
centrifuged at room temperature at the local laboratory on 
the day of collection. Serum was separated, frozen, and 
transported to Kabul for storage and onward shipment. A 
sandwich/indirect ELISA detected speciﬁ  c IgG at a 1:100 
dilution for all human samples by using the VECTOR-
BEST diagnostic kit, (VECTOR-BEST, Novosibirsk, 
Russia). We have previously compared this kit with an 
in-house ELISA (US Army Medical Research Institute 
for Infectious Diseases, Fort Detrick, MD, USA), and the 
results were comparable in all samples tested (L. Mustafa 
et al., unpub. data). We used an in-house ELISA using the 
IbAr 10200 strain of CCHF as antigen (US Army Medical 
Research Institute for Infectious Diseases) and anti-
species IgG horseradish peroxidase–conjugated (KPL 
Inc., Gaithersburg, MD, USA) to test for IgG in all animal 
serum specimens. All positive samples were conﬁ  rmed by 
duplicate testing in a different run. All ELISA testing was 
performed at NAMRU-3.
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Data were analyzed by using Stata version 8 (StataCorp, 
College Station, TX, USA). The primary outcome was 
seropositivity among household members, with secondary 
outcomes being seropositivity in animals and the presence 
of virus in ticks. Exposure factors for seroprevalence were 
identiﬁ  ed on an a priori basis and appropriate measures of 
statistical signiﬁ  cance were applied to detect differences at 
the 95% conﬁ  dence level. The study was approved by the 
ethics boards of NAMRU-3 and the Afghan Public Health 
Institute, Afghanistan.
In total, 330 persons were enrolled from 100 
households. Among our sample, IgG seroprevalence was 
37/330 (11.2%, 95% conﬁ  dence interval [CI] 8.0–15.1). Of 
all the potential explanatory variables, only 2 factors were 
associated with an elevated risk of IgG positivity: daily 
contact with cattle (33/264 [12.5%] vs. 1/52 [1.8%]; χ2 = 
5.1, p = 0.02) and exposure to raw animal skins (24/144 
[16.7%] vs. 12/176 [6.8%]; χ2 = 7.7, p = 0.006). Age group 
was not associated with seroprevalence.
Self reported clinical illness (fever) occurred in 55% 
of participants over a 5-month reporting period. Among the 
participants, 20.8% reported that they had had an illness 
involving bleeding from teeth, gums, and or other parts 
of the body, but this event was not associated with IgG 
positivity or with age group.
These results suggest that the risk for CCHF exposure 
is uniformly high among the population. The oldest age 
group shows an approximate lifetime risk of exposure and 
seroconversion of 17% (95% CI 10.2%–25.8%).
Ninety-two cattle and 40 sheep were included, and 
serologic analysis of their blood samples was conducted. 
Seroprevalence was 79.1% (95% CI 69.0%–87.1%) 
among cattle and 75.0% (95% CI 57.0%–88.5%) among 
sheep. Prevalence was uniformly high regardless of age, 
sex, or origin of the animals, suggesting that the disease 
is highly endemic in the livestock population. Among our 
sample, 84.6% of cattle and 71.5% of sheep had ticks upon 
inspection by the surveyors. Ticks (n = 259) from domestic 
animals were predominantly adult Hyalomma marginatum 
(94.6%). Of the total Hyalomma ticks collected, 83% 
were found on cows. Engorged females were found more 
on cattle than on sheep (43% and 27%, respectively). No 
association was found between tick infestation and animal 
serologic results. Most (>85%) animal owners reportedly 
control ticks by using pesticides. We did not identify virus 
in tick specimens by PCR (5).
Conclusions
Seroprevalence in this population of animal owners 
is higher than in other reported studies from the region 
(3,4), and the risk for exposure appears approximately 
uniform. This ﬁ   nding indicates that universal control 
measures are required. The route of transmission to humans 
is either through the bite of ticks or through contact with 
infected animals or animal products. This second route 
of transmission is probably more important in Iran and 
Afghanistan than tick-borne transmission.
Control of CCHF requires control of the disease vector, 
and surveillance is necessary to ensure optimum timing of 
interventions such as livestock dipping or sponging because 
tick abundance is highly seasonal. Further research on 
rates of antibody acquisition among humans and animals, 
virus transmission dynamics, and effectiveness of disease 
control measures is required. CCHF is a regional public 
health concern of larger than previously acknowledged 
signiﬁ  cance and requires control mechanisms from both 
the health and agriculture sectors.
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